Clinic
Oregon Healthcare Resources, LLC
Oregon Healthcare Resources, LLC was paid $8.76M by Medicaid between Jan 2018 and Dec 2024, across 123 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 28% of everything it billed.
33Billing provider infoOREGON HEALTHCARE RESOURCES, LLC
EUGENE, OR 97401
EUGENE, OR 97401
33aNPI1982907572assigned 12/21/2010
33bProvider typeMulti-Specialty Clinic/Center
28Total paid$8.76M
24GClaims258,668
24DCodes billed123
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Multi-Specialty Clinic/Center providers in Oregon
Rank by total paid#10 of 40
Median peer was paid$517K
This provider vs. median17×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 36,917 | $2.20M | |
| 2019 | 34,840 | $2.10M | |
| 2020 | 25,715 | $766K | |
| 2021 | 30,567 | $896K | |
| 2022 | 35,094 | $887K | |
| 2023 | 51,680 | $1.06M | |
| 2024incomplete | 43,855 | $854K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 28% | 50,631 | 45,572 | $2.44M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 23% | 66,970 | 60,277 | $1.99M |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 6.5% | 5,807 | 5,652 | $569K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 5.7% | 5,698 | 5,268 | $496K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 5.2% | 9,704 | 4,971 | $459K |
| J0585 | Injection, onabotulinumtoxina, 1 unit | 4.5% | 1,342 | 637 | $394K |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 3.7% | 109 | 94 | $323K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 2.9% | 3,505 | 3,200 | $257K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 2.3% | 6,888 | 3,018 | $205K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 2.2% | 2,002 | 1,860 | $193K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 1.7% | 1,350 | 1,220 | $145K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 1.7% | 1,503 | 1,472 | $145K |
111 more codes
| 90686 | 1.6% | 7,821 | $144K | |
| Q5103 | Injection, infliximab-dyyb, biosimilar, (inflectra), 10 mg | 1.3% | 169 | $114K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 1.1% | 1,138 | $97K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 3,151 | $77K |
| 98929 | <1% | 961 | $53K | |
| 98928 | <1% | 1,240 | $51K | |
| 90670 | <1% | 2,120 | $41K | |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 909 | $38K |
| 36415 | Collection of venous blood by venipuncture | <1% | 18,625 | $36K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 326 | $36K |
| 90674 | <1% | 1,598 | $29K | |
| 64615 | <1% | 455 | $28K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,187 | $25K |
| 96415 | <1% | 1,096 | $24K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 618 | $23K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 2,173 | $20K |
| 90723 | <1% | 1,001 | $19K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 975 | $19K |
| 90647 | <1% | 909 | $17K | |
| 73630 | <1% | 657 | $15K | |
| 90680 | <1% | 770 | $15K | |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 755 | $14K |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 1,841 | $13K |
| 95886 | <1% | 130 | $12K | |
| 90677 | <1% | 407 | $11K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 622 | $9K |
| 92567 | <1% | 776 | $9K | |
| 80053 | Comprehensive metabolic panel | <1% | 1,977 | $9K |
| 92557 | <1% | 268 | $6K | |
| 59025 | Fetal non-stress test | <1% | 163 | $6K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 534 | $6K |
| 98927 | <1% | 152 | $6K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 52 | $6K |
| 69210 | <1% | 218 | $5K | |
| 96127 | <1% | 1,218 | $5K | |
| 0072A | <1% | 151 | $5K | |
| 0071A | <1% | 146 | $5K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 1,353 | $5K |
| 90661 | <1% | 203 | $4K | |
| 0001A | <1% | 150 | $4K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,028 | $4K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 73 | $4K |
| 87510 | <1% | 368 | $4K | |
| 87660 | <1% | 369 | $4K | |
| 87480 | <1% | 369 | $4K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 512 | $4K |
| 0012A | <1% | 208 | $4K | |
| 0011A | <1% | 206 | $4K | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 60 | $4K |
| 0002A | <1% | 125 | $4K | |
| 31231 | <1% | 24 | $3K | |
| 97162 | <1% | 41 | $3K | |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | <1% | 21 | $3K |
| 85652 | <1% | 2,000 | $2K | |
| 99173 | <1% | 764 | $2K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 30 | $2K |
| 99459 | <1% | 149 | $2K | |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 19 | $2K |
| 85610 | <1% | 576 | $2K | |
| 85027 | <1% | 469 | $2K | |
| 92504 | <1% | 77 | $2K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 13 | $1K |
| 86140 | <1% | 652 | $1K | |
| 95251 | <1% | 54 | $1K | |
| 20610 | <1% | 31 | $1K | |
| 97803 | <1% | 14 | $1K | |
| 31575 | <1% | 13 | $1K | |
| 90734 | <1% | 51 | $1K | |
| 90633 | <1% | 60 | $1K | |
| 76830 | Ultrasound, transvaginal | <1% | 14 | $1K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 14 | $976.59 |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 70 | $958.00 |
| 90651 | <1% | 45 | $903.00 | |
| 11102 | <1% | 16 | $822.00 | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 51 | $766.66 |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | <1% | 79 | $763.40 |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 43 | $679.66 |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 60 | $549.50 |
| 0054A | <1% | 13 | $448.00 | |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 59 | $432.11 |
| 0003A | <1% | 55 | $396.00 | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 160 | $385.37 |
| 80061 | Lipid panel | <1% | 69 | $346.09 |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 13 | $337.05 |
| 0124A | <1% | 13 | $288.00 | |
| 73610 | <1% | 16 | $225.49 | |
| 81025 | <1% | 28 | $222.43 | |
| 90707 | <1% | 14 | $197.60 | |
| 90716 | <1% | 14 | $197.60 | |
| A9585 | Injection, gadobutrol, 0.1 ml | <1% | 15 | $192.99 |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 13 | $167.28 |
| 87210 | <1% | 14 | $72.60 | |
| 82570 | <1% | 38 | $68.67 | |
| 82043 | <1% | 26 | $43.68 | |
| 99441 | <1% | 47 | $36.25 | |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | <1% | 281 | $27.51 |
| 85014 | <1% | 32 | $26.99 | |
| 85018 | <1% | 32 | $26.99 | |
| 81003 | <1% | 13 | $17.04 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 16 | $2.40 |
| 3078F | 0% | 12,387 | $0.00 | |
| 0502F | 0% | 4,750 | $0.00 | |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 0% | 111 | $0.00 |
| 99442 | 0% | 14 | $0.00 | |
| 3074F | 0% | 16,202 | $0.00 | |
| 3079F | 0% | 748 | $0.00 | |
| 0501F | 0% | 28 | $0.00 | |
| 3075F | 0% | 98 | $0.00 | |
| 3044F | 0% | 28 | $0.00 | |
| 36416 | 0% | 14 | $0.00 | |
| G8991 | Other physical or occupational therapy primary functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 0% | 15 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSHETER, BRENDA (MANAGER BILLING & SUPPORT SERVICES)